Pharmacovigilance Outsourcing Market Top Companies Analysis to Hit $9.65 billion Your Business by 2030

Increase in trends of outsourcing services owing to benefits offered by outsourced compliance providers over in-house compliance functions, and increase in adverse drug reactions and drug toxicity, boost growth of the market.

Increase in trends of outsourcing services owing to benefits offered by outsourced compliance providers over in-house compliance functions, and increase in adverse drug reactions and drug toxicity, boost growth of the market.

The global pharmacovigilance outsourcing market size was valued at $2.48 billion in 2020, and is projected to reach $9.65 billion by 2030 registering a CAGR of 14.60% from 2021 to 2030.

Pharmacovigilance (PV) can be defined as science and activities pertaining to detection, understanding, assessment, and prevention of drug-related problems. It plays a significant role in developing the healthcare system by assessing and monitoring adverse drug interactions and their effects on human. The number of adverse drug reactions (ADRs) reported during the last few years has increased to a great extent and requires high level of expertise in pharmacovigilance to rapidly detect drug risks and defend products against recalls.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/11280

COVID-19 is a large family of viruses that causes illness ranging from common cold to more severe respiratory diseases. The COVID-19 pandemic has helped the industry grow significantly, as the demand for pharmacovigilance outsourcing services increased. Medical monitoring and safety reporting are essential as several potential therapies are being used in the treatment of coronavirus-induced infection. In addition, rising incidence of adverse drug reactions is anticipated to accelerate the demand for pharmacovigilance services amid pandemics. This supports the pharmacovigilance outsourcing market to gain traction during the forecast period.

Pharmacovigilance outsourcing refers to transfer of drug safety processes and functions to a third-party provider. These services are majorly outsourced by small and mid-size pharmaceutical and biotechnology companies with an aim to save costs and focus on company’s core activities. Some of the common pharmacovigilance activities that are generally outsourced include collecting ADR information, case processing activities, development of risk management plans & risk evaluation mitigation strategy as well as creating & submitting aggregate and expedited pharmacovigilance reports.

The pharmacovigilance outsourcing market is segmented on the basis of type, service providers, end user, and region.

By type, the market is divided into adverse drug reaction capture (ADR), case processing, reporting and submission, report publishing, quality check, risk management, knowledge management, and enabling architecture. The case processing segment dominated the global market in 2020, and is anticipated to continue this trend during the forecast period.

On the basis of service providers, it is segmented into contract research organizations and business processing outsourcing. The contract research organizations segment dominated the global market in 2020, and is expected to remain dominant throughout the forecast period.

By end user, it is divided into pharmaceutical industry, research organization, and others. The others segment is further divided into regulatory organizations and hospitals. The pharmaceutical industry segment held the largest market share in 2020, and is expected to remain dominant throughout the forecast period

North America accounted for the largest share of the global pharmacovigilance outsourcing market in 2020, and is expected to remain dominant throughout the forecast period. This was attributed to presence of major pharma and medical device companies in the region.

Access Full Report: https://www.alliedmarketresearch.com/pharmacovigilance-outsourcing-market-A10915

The Major Key Players Are:

Accenture PLC., Bioclinica, Capgemini (IGate Corporation), Cognizant Technology Solutions Corporation, Ergomed Plc., Genpact Limited, International Business Machines Corporation, Icon Plc., IQVIA Holdings Inc. (Clintec), and Labcorp Drug Development (Covance).

Trending Reports:

Direct Fed Microbial Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

Life Science Analytics Software Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa

5933 NE Win Sivers Drive

#205, Portland, OR 97220

United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

help@alliedmarketresearch (dot) com